Cargando…
Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein
BACKGROUND: The recent emergence of a novel pandemic influenza A(H1N1) strain in humans exemplifies the rapid and unpredictable nature of influenza virus evolution and the need for effective therapeutics and vaccines to control such outbreaks. However, resistance to antivirals can be a formidable pr...
Autores principales: | Triana-Baltzer, Gallen B., Gubareva, Larisa V., Nicholls, John M., Pearce, Melissa B., Mishin, Vasiliy P., Belser, Jessica A., Chen, Li-Mei, Chan, Renee W. Y., Chan, Michael C. W., Hedlund, Maria, Larson, Jeffrey L., Moss, Ronald B., Katz, Jacqueline M., Tumpey, Terrence M., Fang, Fang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770640/ https://www.ncbi.nlm.nih.gov/pubmed/19893747 http://dx.doi.org/10.1371/journal.pone.0007788 |
Ejemplares similares
-
Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
por: Triana-Baltzer, Gallen B., et al.
Publicado: (2009) -
A Safety Evaluation of DAS181, a Sialidase Fusion Protein, in Rodents
por: Larson, Jeffrey L., et al.
Publicado: (2011) -
An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
por: Marjuki, Henju, et al.
Publicado: (2014) -
A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses
por: De Marco, Donata, et al.
Publicado: (2012) -
The use of sialidase therapy for respiratory viral infections
por: Nicholls, John M., et al.
Publicado: (2013)